From: Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study
 | N (N = 110) | % |
---|---|---|
Use as indicated by FDA label | Â | Â |
5-fluorouracil included in the regimen | 82 | 75 |
5-fluorouracil not included in the regimen | 15 | 14 |
Unable to determine 5-fluorouracil use | 13 | 12 |
Chemotherapy give in combination with bevacizumab | Â | Â |
5-fluorouracil plus oxaliplatin | 51 | 46 |
5-fluorouracil plus irinotecan | 21 | 19 |
Capecitabine plus oxaliplatin | 8 | 7 |
Capecitabine plus irinotecan | 1 | 1 |
5-fluorouracil alone | 9 | 8 |
Capecitabine alone | 5 | 5 |
Other | 15 | 14 |